Comparison of PD-L1 mRNA Expression Measured with the CheckPoint Typer® Assay with PD-L1 Protein Expression Assessed with Immunohistochemistry in Non-small Cell Lung CancerRamona Erber, Wolfgang M. Brueckl, Ralf J. Rieker et al.|Anticancer Research|2017Cited by 26
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)Frank Griesinger, Dimitri Flieger, Wilfried Eberhardt et al.|JTO Clinical and Research Reports|2023Cited by 4